VRAX
Virax Biolabs Group·NASDAQ
--
--(--)
--
--(--)
1.51 / 10
Underperform
Technical composite is weak (1.51/10). No bullish confirmations; MACD Golden Cross and Death Cross both evaluate to 'Biased bearish,' and Long Lower Shadow is merely 'Neutral rise.' Recent indicator logs (last 5 days) confirm three bearish signals versus zero bullish, highlighting an elevated downside risk.
Analysis Checks(0/3)
Long Lower Shadow
Score2.53/10
Win Rate45.76%
Hist. Signals59
Avg Return0.33%
Score2.53/10
Win Rate45.76%
Hist. Signals59
Avg Return0.33%
MACD Golden Cross
Score1/10
Win Rate9.09%
Hist. Signals11
Avg Return-9.20%
Score1/10
Win Rate9.09%
Hist. Signals11
Avg Return-9.20%
MACD Death Cross
Score1/10
Win Rate22.22%
Hist. Signals9
Avg Return-6.76%
Score1/10
Win Rate22.22%
Hist. Signals9
Avg Return-6.76%
Long Lower Shadow
Score2.53/10
Win Rate45.76%
Hist. Signals59
Avg Return0.33%
Score2.53/10
Win Rate45.76%
Hist. Signals59
Avg Return0.33%
MACD Death Cross
Score1/10
Win Rate22.22%
Hist. Signals9
Avg Return-6.76%
Score1/10
Win Rate22.22%
Hist. Signals9
Avg Return-6.76%
MACD Golden Cross
Score1/10
Win Rate9.09%
Hist. Signals11
Avg Return-9.20%
Score1/10
Win Rate9.09%
Hist. Signals11
Avg Return-9.20%
What is the current technical signals for VRAX?
- VRAX presents a Underperform setup with a Technical Score of 1.51/10. Key technical indicators highlight an RSI of 29.62 and a MACD of -0.00, with the trend anchored by the 50-Day SMA at 0.37. Traders should monitor key support at 0.22 and resistance at 0.23.
